Qinghua Feng

Qinghua Feng

Auto-generated profile, based on publicly available information

Qinghua Feng

University of Washington, 1959 NE Pacific St., Seattle, WA, 98195, USA.

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2015 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
JDJuliet Dang
Juliet Dang
QFQinghua Feng
Qinghua Feng
KEKeith D. Eaton
Keith D. Eaton
HJHona Jang
Hona Jang
NKNancy B. Kiviat
Nancy B. Kiviat
Due to the increasing rates of oropharyngeal cancer, oral HPV infection is a significant concern. Methods for detecting oral HPVs is not standardized as there are different techniques available. We propose that use of oral rinse samples to detect for HPVs is a suitable technique within a clinic setting. Thus, our main objective is to study HPV detection in oral rinse samples. In our study, we used oral rinse sample collection coupled with real-time PCR to detect for HPVs types 16 and 18, and preferentially amplified FAP PCR samples to detect for a broad range of HPVs, in oropharyngeal squamous cell carcinoma (OPSCC), non-OPSCC, and healthy patients. Thirty three percent of 100 cancer patients were positive for any type of HPV; of those 23 were positive for HPV16. Only 1 of 110 healthy controls was positive (this subject was positive for HPV18). Our results indicate that HPV detection in oral rinse samples may be useful as a screening tool to detect HPV-associated oral cancers.

14 June 2012
Verified
Book Chapter
Closed access
PDF file
SCStephen Cherne
Stephen Cherne
VPViorica Popov
Viorica Popov
QFQinghua Feng
Qinghua Feng

1 August 2012 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
YAYuzo Arima
Yuzo Arima
RWRachel Winer
Rachel Winer
AKAnn E. Kurth
Ann E. Kurth
DMDiane P. Martin
Diane P. Martin
JHJames P. Hughes
James P. Hughes
LKLaura A. Koutsky
Laura A. Koutsky
A survey was administered to male university students who tested positive for high-risk human papillomavirus. Disclosure was more likely in men with fewer partners, in main partnerships, and in longer partnerships. Disclosure was associated with discussing the Pap test/human papillomavirus vaccine with female partners and not associated with a worsening relationship.